Skip to content

Medical-device intelligence

PWE: Computerized Behavioral Therapy Device For Substance Use Disorders

FDA product code PWE: Computerized Behavioral Therapy Device For Substance Use Disorders. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PWE
FDA device name
Computerized Behavioral Therapy Device For Substance Use Disorders
Device class
2
Regulation number
882.5801
Medical specialty
Neurology
Review panel
NE

FDA definition

The device is intended to provide cognitive behavioral therapy to treat substance use disorder.
Explore neurology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

1 clearance records and 2 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Dec 10, 2018 to Jun 7, 2021.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
reSET Mobile App, iOS and Android, provides cognitive behavioral therapy, as part of substance abuse treatment.Z-1925-2021 · PWEPear Therapeutics, Inc.RecallJun 21, 2021FDA record creation date
reSET-O Mobile App, iOS and Android, provides cognitive behavioral therapy, as part of substance abuse treatment.Z-1926-2021 · PWEPear Therapeutics, Inc.RecallJun 21, 2021FDA record creation date
reSET-OK173681 · PWEPear Therapeutics, Inc.510(k)Dec 10, 2018FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗